Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
2 Apr 2026
AI Uses Eye-Tracking Technology to Diagnose Autism
AI can distinguish children with autism spectrum disorder using eye-tracking technology with an accuracy of 85%, a 2026 systematic review has found.
2 Apr 2026
More Than One Million People to be Offered Semaglutide on NHS
Semaglutide is set to be offered to more than one million people with cardiovascular disease on the NHS in coming months.
Lilly’s weight loss pill wins FDA approval
Eli Lilly won FDA approval on 1 April 2026 for a once-daily oral GLP-1, orforglipron.
2 Apr 2026
Urinary Metabolites Identify Bladder Cancer and Predict Recurrence
Urinary metabolites may help detect bladder cancer and predict recurrence, offering a potential non-invasive tool to improve patient monitoring and outcomes.
2 Apr 2026
New Trial Shows TENS Improves Pain in Fibromyalgia
Cluster trial shows TENS improves fibromyalgia pain with meaningful reductions sustained over six months and high patient satisfaction rates.
2 Apr 2026
Stopping RAS Inhibitors After eGFR Fall May Increase Risk
Stopping RAS inhibitors after an eGFR decline may increase risk of kidney failure and death, according to a large cohort study.
2 Apr 2026
Rapid Test Detects Acute Respiratory Distress Syndrome Subtypes
Rapid testing identifies acute respiratory distress syndrome subtypes linked to mortality, supporting precision medicine in critical care.
2 Apr 2026
Umbilical Cord Antiseptics May Reduce Neonatal Mortality
Topical application of 4.0% chlorhexidine to the umbilical cord may reduce neonatal mortality in low- and middle-income countries, a 2026 review has found.
11
Mins
2 Apr 2026
GI Challenges in Parkinson’s Disease
Parkinson’s disease (PD) affects at least 1% of people aged over 60 years and 2–3% of those aged over 65 years. PD is reported to be the…
Supply chains and trials hit by Middle East instability
Pharma companies are facing renewed pressure due to instability linked to the Middle East conflict.
←
1
2
3
…
17
18
19
20
21
22
23
…
1,439
1,440
1,441
→
We’ve noticed you’re accessing
from
North/South America.
View
View